Proposals include ITC relief on free samples and expired drugs, while a 90 per cent refund of accumulated credit could ease working-capital pressure for drugmakers
Read more at Business Standard
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.